VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Feb 21, 2023
Document Date
Feb 16, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
MORAN KEVIN PATRICK
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |